• SENSEX 73,257.62
    -341.05 (--0.46%)
  • BANKNIFTY 53,974.90
    -391.80 (--0.72%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,161.90 1,152.30(%)
  • Piramal Pharma
    235.45 231.85(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    189.95 227.00(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Cholaman.Inv.&Fn
    1,555.00 1,952.00(%)
  • Acutaas Chemical
    3,690.00 1,571.20(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • One 97
    1,640.50 1,856.50(%)
  • Ola Electric
    37.44 51.84(%)
  • Sahajanand Medi
    482.10 347.50(%)
  • Bajaj Finance
    918.00 1,177.60(%)
  • Swiggy
    183.05 174.30(%)
  • Infosys
    1,103.50 980.30(%)
  • Patanjali Foods
    352.00 613.95(%)
  • Netweb Technol.
    4,490.00 5,810.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Themis Biosyn Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Themis
  • BSE Code : 216.0
  • ISIN : INE942C01045
352.60 15 (4.35%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    334.85

  • Today’s High

    357.55

  • Open

    338.00

  • Perv Close

    337.90

  • 52W Low

    225.05

  • 52W High

    479.00

Key Indicators

  • P/E(TTM)

    94.24

  • Mar.Cap (₹Cr.)

    4,589.15

  • Div & Yield %

    0.16

  • Book Value(₹)

    79.74

  • Debt-Equity Ratio

    4.35

  • AGM Date

    27-Oct-2026

  • EPS

    3.74

  • P/E Ratio

    94.24

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    4,589.15

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.02

  • BV (₹)

    79.70

  • Sales( ₹ in Cr.)

    165.82

  • NP (in Cr.)

    46.68

  • NP Var(%)

    -4.0

  • Div%

    67.0

  • CPS (₹)

    4.60

  • EPS (₹)

    3.60

  • Traded Value (₹ in Lakhs)

    4,587.20

  • 52 Week High

    479.00

  • 52 Week Low

    225.05

  • Price BSE

    352.0

  • Price NSE

    353.00

  • Market Capital( in Cr.)

    4,587.20

  • P/C Ratio

    76.90

  • P/E Ratio

    98.10

  • Price Vs.BV

    3.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 165.82 150.80 169.82 148.39 114.85 90.56
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 165.82 150.80 169.82 148.39 114.85 90.56
Other Income 2.43 2.44 4.38 6.59 4.05 3.27
Stock Adjustments 9.03 1.27 -11.01 3.24 5.13 0.38
Total Income 177.28 154.51 163.19 158.22 124.03 94.21
EXPENDITURE :            
Raw Materials 30.43 25.78 25.67 29.73 21.75 15.75
Power and Fuel Cost 31.89 26.63 26.53 26.41 21.73 16.57
Employee Cost 14.99 11.44 10.21 7.75 7.08 7.11
Other Manufacturing Expenses 7.75 9.20 6.79 6.80 7.91 8.79
Selling and Administration Expenses 8.37 5.81 8.59 6.66 2.31 1.86
Miscellaneous Expenses 5.01 4.36 2.29 0.64 1.15 0.53
Employee Benefit Expenses 14.99 11.44 10.21 7.75 7.08 7.11
Less: Preoperative Expenditure 0.00 -0.01 -0.01 0.00 0.00 0.00
Total Expenses 98.43 83.24 80.09 77.99 61.94 50.61
Operating Profit 78.85 71.27 83.10 80.22 62.10 43.59
Interest 3.84 0.36 0.23 0.18 0.83 0.98
Gross Profit 75.01 70.91 82.87 80.04 61.27 42.61
Depreciation 12.92 5.37 3.54 2.58 2.23 1.73
Profit Before Tax 62.09 65.54 79.33 77.46 59.04 40.88
Current Tax 10.79 16.49 19.80 19.24 15.34 10.58
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.62 0.28 0.38 0.26 0.07 0.13
Reported Net Profit 46.68 48.77 59.16 57.97 43.62 30.18
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.01
Adjusted Net Profit 46.68 48.77 59.16 57.97 43.62 30.17
Adjustment below Net Profit 0.01 -1.42 -0.03 0.06 -0.08 -0.03
P & L Balance brought forward 237.33 191.79 139.56 93.74 60.36 32.61
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 7.30 1.82 6.90 12.20 10.17 2.40
P & L Balance carried down 276.71 237.33 191.79 139.56 93.74 60.36
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 67.00 67.00 100.00 108.00 220.00 0.00
Dividend Per Share(Rs) 0.67 0.67 1.00 5.40 11.00 0.00
Earnings Per Share-Unit Curr 4.28 4.48 8.14 39.90 30.03 20.77
Earnings Per Share(Adj)-Unit Curr 4.28 4.48 5.43 5.32 4.00 2.77
Book Value 26.41 22.79 27.72 102.66 71.11 48.14
Book Value(Adj)-Unit Curr 26.41 22.79 18.48 13.69 9.48 6.42

Shareholding Pattern

  • Promoter Group

    59.33%

  • Public Share Holding

    40.67%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 73,491,287 56.47 73,491,287 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,726,796 2.86 3,726,791 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 77,218,083 59.33 77,218,078 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 750 0.00 750 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 250 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,944,331 3.80 4,944,331 25
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,824,859 2.17 2,824,859 1
Mutual Funds / UTI 12,537,004 9.63 12,523,004 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,099,371 0.84 1,089,121 5
Trusts 750 0.00 750 1
Venture Capital Funds 0 0.00 0 0
Sub total 21,407,315 16.45 21,382,815 41
2] Non Institution
Bodies Corporate 6,266,273 4.81 6,239,273 202
Clearing Members 241,982 0.19 241,982 19
Directors of their Relatives 169,770 0.13 169,770 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,342,931 1.03 1,207,681 778
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,342,457 1.03 1,342,457 529
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,405,593 3.39 4,405,593 11
Individuals holding nominal share capital up to Rs. 1 lakh 17,118,498 13.15 16,177,663 27,171
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 250 0.00 0 1
Others 0 0.00 0 0
Sub Total 31,526,307 24.22 30,422,472 28,731
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 130,151,705 100.00 129,023,365 28,781

Company Background

Gujarat Themis Biosyn LtdPharmaceuticals - Indian - Bulk Drugs

  • Gujarat Themis Biosyn Ltd
  • BSE Code : 216.0
  • ISIN : INE942C01045

  • Incorporation Year

    1981

  • Registered Office

    69/C GIDC Industrial Estate
    Valsad Dist, VAPI,
    Gujarat-396195

  • Telephone

    91-260-2430027

  • FAX

    91-260-2400639

  • Chairman

    Dinesh S Patel

  • Managing Director

    Sachin D Patel

  • Company Secretary

    Vineet Gawankar

  • Auditor

    GMJ & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gujarat Themis Biosyn Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Themis Bio. 352.45 168.25 165.82 94.24 18.05
Abbott India 25,488.50 7,217.19 6,929.05 33.54 43.78
Astrazeneca Phar 6,073.10 2,304.07 2,275.58 89.51 27.86
Sanofi India 3,066.25 1,857.10 1,837.40 21.81 54.17
Glaxosmi. Pharma 2,488.75 3,932.76 3,790.20 39.76 58.17
Novartis India 1,847.40 393.10 354.33 46.65 15.94
Cipla 1,350.00 20,102.60 18,979.95 41.15 13.88
Bliss GVS Pharma 643.55 773.53 729.81 59.81 12.51
Amrutanjan Healt 490.45 520.13 502.55 26.27 24.16
Fermenta Biotec. 449.00 474.15 450.25 20.96 18.77
Ambalal Sarabhai 35.40 19.52 3.94 65.56 6.77